Found: 32
Select item for more details and to access through your institution.
Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a): A Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 331, n. 18, p. 1534, doi. 10.1001/jama.2024.4504
- By:
- Publication type:
- Article
A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 4, p. 743, doi. 10.1007/s10557-022-07328-w
- By:
- Publication type:
- Article
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results.
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 3, p. 1, doi. 10.1161/JAHA.122.027540
- By:
- Publication type:
- Article
An evaluation of a supratherapeutic dose of inclisiran on cardiac repolarization in healthy volunteers: A phase I, randomized study.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 11, p. 2663, doi. 10.1111/cts.13391
- By:
- Publication type:
- Article
Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prognostic usefulness of planar <sup>123</sup>I-MIBG scintigraphic images of myocardial sympathetic innervation in congestive heart failure: Follow-Up data from ADMIRE-HF.
- Published in:
- 2021
- By:
- Publication type:
- journal article
MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High-Density Lipoprotein, and Low-Density Lipoprotein Receptor-Mediated Reverse Cholesterol Transport.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Immunogenicity of a Live-Attenuated Dengue Vaccine Using a Heterologous Prime-Boost Strategy in a Phase 1 Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.640190
- By:
- Publication type:
- Article
A Comparison of Ezetimibe and Evolocumab for Atherogenic Lipid Reduction in Four Patient Populations: A Pooled Efficacy and Safety Analysis of Three Phase 3 Studies.
- Published in:
- Cardiology & Therapy, 2020, v. 9, n. 2, p. 447, doi. 10.1007/s40119-020-00181-8
- By:
- Publication type:
- Article
Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects.
- Published in:
- Vascular Health & Risk Management, 2020, v. 16, p. 403, doi. 10.2147/VHRM.S261719
- By:
- Publication type:
- Article
Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1649, doi. 10.1002/ejhf.1933
- By:
- Publication type:
- Article
Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I Study.
- Published in:
- American Journal of Tropical Medicine & Hygiene, 2020, v. 102, n. 5, p. 951, doi. 10.4269/ajtmh.19-0461
- By:
- Publication type:
- Article
Does prior dengue virus exposure worsen clinical outcomes of Zika virus infection? A systematic review, pooled analysis and lessons learned.
- Published in:
- PLoS Neglected Tropical Diseases, 2019, v. 13, n. 1, p. 1, doi. 10.1371/journal.pntd.0007060
- By:
- Publication type:
- Article
Consistent LDL‐C response with evolocumab among patient subgroups in PROFICIO: A pooled analysis of 3146 patients from phase 3 studies.
- Published in:
- Clinical Cardiology, 2018, v. 41, n. 10, p. 1328, doi. 10.1002/clc.23049
- By:
- Publication type:
- Article
Comparison of LDL-C Reduction Using Different Evolocumab Doses and Intervals: Biological Insights and Treatment Implications.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina.
- Published in:
- Headache: The Journal of Head & Face Pain, 2018, v. 58, n. 5, p. 715, doi. 10.1111/head.13316
- By:
- Publication type:
- Article
Evaluation of the efficacy, safety and glycaemic effects of evolocumab ( AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 1, p. 98, doi. 10.1111/dom.12788
- By:
- Publication type:
- Article
Type-specific clinical characteristics of adenovirus-associated influenza-like illness at five US military medical centers, 2009-2014.
- Published in:
- Influenza & Other Respiratory Viruses, 2016, v. 10, n. 5, p. 414, doi. 10.1111/irv.12392
- By:
- Publication type:
- Article
The Epidemiology of Herpes Simplex Virus Type 2 Infections in a Large Cohort of HIV-infected Patients, 2006-2014.
- Published in:
- MSMR, 2016, v. 23, n. 3, p. 11
- By:
- Publication type:
- Article
Effect of PCSK9 Inhibition by Alirocumab on Lipoprotein Particle Concentrations Determined by Nuclear Magnetic Resonance Spectroscopy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Insights Into Statin Intolerance.
- Published in:
- 2015
- By:
- Publication type:
- Other
The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials.
- Published in:
- European Heart Journal, 2015, v. 36, n. 24, p. 1536, doi. 10.1093/eurheartj/ehv072
- By:
- Publication type:
- Article
Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials.
- Published in:
- European Heart Journal, 2014, v. 35, n. 33, p. 2249
- By:
- Publication type:
- Article
Characterization of infections with extended-spectrum β-lactamase producing Escherichia coli and Klebsiella species at a major military medical center.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Efficacy and safety of 30-minute infusions of conivaptan in euvolemic and hypervolemic hyponatremia.
- Published in:
- American Journal of Health-System Pharmacy, 2011, v. 68, n. 9, p. 818, doi. 10.2146/ajhp100260
- By:
- Publication type:
- Article
Impact of High-Dose Atorvastatin in Coronary Heart Disease Patients Age 65 to 78 Years.
- Published in:
- Clinical Cardiology, 2009, v. 32, n. 5, p. 256, doi. 10.1002/clc.20448
- By:
- Publication type:
- Article
Efficacy and safety of oral conivaptan: a V<sub>1A</sub>/V<sub>2</sub> vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Filling cystoureterography facilitates stone visualization in patients with previously inserted double-J ureteral stents.
- Published in:
- Urological Research, 2005, v. 33, n. 3, p. 203, doi. 10.1007/s00240-004-0449-z
- By:
- Publication type:
- Article
A dose-ranging study of a new, once-daily, dual-component drug product containing niacin extended-release and lovastatin.
- Published in:
- Clinical Cardiology, 2003, v. 26, n. 3, p. 112, doi. 10.1002/clc.4960260304
- By:
- Publication type:
- Article
Left ventricular mass change during treatment and outcome in patients with essential hypertension.
- Published in:
- American Journal of Hypertension, 2002, v. 15, n. 12, p. 1021, doi. 10.1016/S0895-7061(02)03061-3
- By:
- Publication type:
- Article
Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension.
- Published in:
- 1991
- By:
- Publication type:
- journal article